QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(I.R.S Employer Identification No.) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
☒ | Smaller reporting company | |||||
Emerging growth company |
• | Part I, Item 1, Financial Statements |
• | Part I, Item 2, Management’s Discussion and Analysis of Financial Condition and Results of Operations |
• | Part I, Item 4, Controls and Procedures |
• | Part II, Item 1, Risk Factors |
• | Part II, Item 6, Exhibits and Signatures |
6 |
||||||
Item 1. |
6 |
|||||
Item 2. |
40 |
|||||
Item 3. |
56 |
|||||
Item 4. |
57 |
|||||
58 |
||||||
Item 1. |
58 |
|||||
Item 1A. |
58 |
|||||
Item 2. |
58 |
|||||
Item 3. |
58 |
|||||
Item 4. |
58 |
|||||
Item 5. |
58 |
|||||
Item 6. |
58 |
|||||
60 |
• | the ability of Dave to compete in its highly competitive industry; |
• | the ability of Dave to keep pace with the rapid technological developments in its industry and the larger financial services industry; |
• | the ability of Dave to manage its growth as a public company; |
• | the ability of Dave to protect intellectual property and trade secrets; |
• | changes in applicable laws or regulations and extensive and evolving government regulations that impact operations and business; |
• | the ability to attract or maintain a qualified workforce; |
• | level of product service failures that could lead Dave members (“Members”) to use competitors’ services; |
• | investigations, claims, disputes, enforcement actions, litigation and/or other regulatory or legal proceedings; |
• | the ability to maintain the listing of Dave Class A Common Stock on Nasdaq; |
• | the effects of the COVID-19 pandemic, the Russia-Ukraine war or rising inflation on Dave’s business; |
• | the possibility that Dave may be adversely affected by other economic, business, and/or competitive factors; and |
• | other risks and uncertainties described in this Form 10-Q, including those described under Item 1A, “Risk Factors” of the Annual Report. |
As of March 31, 2022 |
As of December 31, 2021 |
|||||||
(unaudited) |
||||||||
(As Restated) |
||||||||
Assets |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ |
$ |
||||||
Marketable securities |
||||||||
Member advances, net of allowance for unrecoverable advances of $ 31, |
||||||||
Prepaid income taxes |
||||||||
Deferred issuance costs |
— |
|||||||
Prepaid expenses and other current assets |
||||||||
|
|
|
|
|||||
Total current assets |
||||||||
Property and equipment, net |
||||||||
Lease right-of-use assets (related-party of $ 2021, respectively) |
||||||||
Intangible assets, net |
||||||||
Derivative asset on loans to stockholders |
— |
|||||||
Debt facility commitment fee, long-term |
||||||||
Restricted cash, net of current portion |
||||||||
|
|
|
|
|||||
Total assets |
$ |
$ |
||||||
|
|
|
|
|||||
Liabilities, and stockholders’ equity |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ |
$ |
||||||
Accrued expenses |
||||||||
Lease liabilities, short-term (related-party of $ |
||||||||
Legal settlement accrual |
||||||||
Note payable |
— |
|||||||
Credit facility |
||||||||
Convertible debt, current |
— |
|||||||
Interest payable, convertible notes, current |
— |
|||||||
Other current liabilities |
||||||||
|
|
|
|
|||||
Total current liabilities |
||||||||
Lease liabilities, long-term (related-party of $ |
||||||||
Debt facility, long-term |
||||||||
Convertible debt, long-term |
— |
|||||||
Warrant liabilities |
||||||||
Earnout liabilities |
— | |||||||
Other non-current liabilities |
||||||||
|
|
|
|
|||||
Total liabilities |
||||||||
|
|
|
|
|||||
Commitments and contingencies (Note 15) |
||||||||
Stockholders’ equity: |
||||||||
Preferred stock, par value per share $ |
|
|
|
|
|
|
— |
|
Class A common stock, par value per share $ |
||||||||
Class V common stock, par value per share $ issued and outstanding at March 31, 2022 and December 31, 2021, respectively; |
||||||||
Treasury stock |
–— |
( |
) | |||||
Additional paid-in capital |
||||||||
Loans to stockholders |
–— |
( |
) | |||||
Accumulated deficit |
( |
) |
( |
) | ||||
|
|
|
|
|||||
Total stockholders’ equity |
||||||||
|
|
|
|
|||||
Total liabilities, and stockholders’ equity |
$ |
$ |
||||||
|
|
|
|
For the Three Months Ended |
||||||||
March 31, 2022 |
March 31, 2021 |
|||||||
(As Restated) |
||||||||
Operating revenues: |
|
|
| |||||
Service based revenue, net |
$ | $ | ||||||
Transaction based revenue, net |
||||||||
|
|
|
|
|||||
Total operating revenues, net |
||||||||
|
|
|
|
|||||
Operating expenses: |
||||||||
Provision for unrecoverable advances |
||||||||
Processing and servicing fees |
||||||||
Advertising and marketing |
||||||||
Compensation and benefits |
||||||||
Other operating expenses |
||||||||
|
|
|
|
|||||
Total operating expenses |
||||||||
|
|
|
|
|||||
Other (income) expenses: |
||||||||
Interest income |
( |
) | ( |
) | ||||
Interest expense |
||||||||
Legal settlement and litigation expenses |
||||||||
Other strategic financing and transactional expenses |
||||||||
Changes in fair value of derivative asset on loans to stockholders |
( |
) | ||||||
Changes in fair value of warrant liabilities |
||||||||
Changes in fair value of earnout liabilities |
( |
) | — | |||||
|
|
|
|
|||||
Total other (income) expense, net |
( |
) | ||||||
|
|
|
|
|||||
Net (loss) income before provision (benefit) for income taxes |
( |
) |
||||||
Provision (benefit) for income taxes |
( |
) | ||||||
|
|
|
|
|||||
Net (loss) income |
$ |
( |
) |
$ |
||||
|
|
|
|
|||||
Net (loss) income per share: |
||||||||
Basic |
$ | ( |
) | $ | ||||
Diluted |
$ | ( |
) | $ | ||||
Weighted-average shares used to compute net (loss) income per share |
||||||||
Basic |
||||||||
Diluted |
Common stock |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series A convertible preferred stock |
Series B-1 convertible preferred stock |
Series B-2 convertible preferred stock |
Common stock |
Class A |
Class V |
Additional paid-in capital |
Loans to stockholders |
Treasury stock |
Accumulated deficit |
Total stockholders’ equity |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Shares |
Amount |
Shares |
Amount |
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance at January 1, 2022 (as previously reported) |
$ |
$ |
$ |
$ |
— |
$ |
— |
— |
$ |
— |
$ |
$ |
( |
) |
( |
) |
$ |
( |
) |
$ |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Retroactive application of recapitalization |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) |
— |
— |
— |
|||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
Balance at January 1, 2022 (as adjusted) |
— |
— |
— |
— |
— |
— |
— |
— |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of Class A common stock for stock option exercises |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of Class A common stock pursuant to the PIPE financing |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of Class A common stock pursuant to the Merger Agreement (As Restated) |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
( |
) |
— |
— |
— |
( |
) | |||||||||||||||||||||||||||||||||||||||||||||||||||
Exercise of Series B-1 preferred stock warrants, net of settlement |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Conversion of 2019 convertible notes and accrued interest to Class A common stock |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Repurchase of Class A common stock |
— |
— |
— |
— |
— |
— |
— |
— |
( |
) |
— |
— |
— |
( |
) |
— |
— |
( |
) | |||||||||||||||||||||||||||||||||||||||||||||||||
Exercise of warrant for Class A common stock |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholder loans interest |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
( |
) |
— |
— |
( |
) | |||||||||||||||||||||||||||||||||||||||||||||||||
Exercise of derivative asset and paydown of stockholder loans |
— |
— |
— |
— |
— |
— |
— |
— |
( |
) |
( |
) |
— |
— |
( |
) |
— |
— |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
|||||||||||||||||||||||||||||||||||||||||||||||||||||
Net loss (As Restated) |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
( |
) |
( |
) | |||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
Balance at March 31, 2022 (As Restated) |
— |
$ |
— |
— |
$ |
— |
— |
$ |
— |
— |
$ |
— |
$ |
$ |
— |
$ |
— |
$ |
( |
) |
$ |
|||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
Common stock |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series A convertible preferred stock |
Series B-1 convertible preferred stock |
Series B-2 convertible preferred stock |
Common stock |
Class A |
Class V |
Additional paid-in capital |
Loans to stockholders |
Treasury stock |
Accumulated deficit |
Total stockholders’ equity |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Shares |
Amount |
Shares |
Amount |
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance at January 1, 2021 (as previously reported) |
$ |
$ |
$ |
$ |
— |
$ |
— |
$ |
— |
— |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||||||||||||||||||||||||||||
Retroactive application of recapitalization |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) |
— |
— |
— |
|||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
Balance at January 1, 2021 (as adjusted) |
— |
— |
— |
— |
— |
— |
— |
— |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock for stock option exercises |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholder loans interest |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
( |
) |
— |
— |
( |
) | |||||||||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
|||||||||||||||||||||||||||||||||||||||||||||||||||||
Net income |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
|||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
Balance at March 31, 2021 |
— |
$ |
— |
— |
$ |
— |
— |
$ |
— |
— |
$ |
— |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
|||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dave Inc. and Subsidiaries |
Condensed Consolidated Statements of Cash Flows |
(in thousands) |
( unaudited) |
For the Three Months Ended March 31, |
||||||||
2022 |
2021 |
|||||||
(As Restated) |
(As Restated) |
|||||||
Operating activities |
||||||||
Net (loss) income |
$ |
( |
) |
$ |
||||
Adjustments to reconcile net (loss) income to net cash used in operating activities: |
||||||||
Depreciation and amortization |
||||||||
Provision for unrecoverable advances |
||||||||
Changes in fair value of derivative assets |
( |
) | ||||||
Changes in fair value of warrant liabilities |
||||||||
Changes in fair value of earnout liabilities |
( |
) | — | |||||
Stock-based compensation |
||||||||
Non-cash interest |
( |
) |
( |
) | ||||
Non-cash lease expense |
( |
) |
( |
) | ||||
Changes in fair value of marketable securities |
( |
) | ||||||
Changes in operating assets and liabilities: |
||||||||
Member advances, service revenue |
( |
) |
||||||
Prepaid income taxes |
||||||||
Prepaid expenses and other current assets |
( |
) |
( |
) | ||||
Accounts payable |
||||||||
Accrued expenses |
( |
) |
||||||
Income taxes payable |
— |
|||||||
Legal settlement accrual |
( |
) |
— |
|||||
Other current liabilities |
( |
) |
( |
) | ||||
Other non-current liabilities |
( |
) | ||||||
Interest payable, convertible notes |
— |
|||||||
|
|
|
|
|||||
Net cash used in operating activities |
( |
) |
( |
) | ||||
|
|
|
|
|||||
Investing activities |
||||||||
Payments for internally developed software costs |
( |
) |
( |
) | ||||
Purchase of property and equipment |
( |
) |
( |
) | ||||
Net disbursements and collections of Member advances |
( |
) | ||||||
Purchase of marketable securities |
( |
) |
( |
) | ||||
Sale of marketable securities |
||||||||
|
|
|
|
|||||
Net cash (used in) provided by investing activities |
( |
) |
||||||
|
|
|
|
|||||
Financing activities |
||||||||
Repayment on line of credit |
— |
( |
) | |||||
Proceeds from PIPE offering |
— |
|||||||
Proceeds from escrow account, net of redemptions |
— |
|||||||
Payment of issuance costs |
|
|
( |
) |
|
|
( |
) |
Proceeds from issuance of common stock for stock option exercises |
||||||||
Repurchase of common stock |
( |
) |
— |
|||||
Proceeds from borrowings on convertible debt |
— |
|||||||
Proceeds from borrowings on debt and credit facilities |
— |
|||||||
|
|
|
|
|||||
Net cash provided by financing activities |
||||||||
|
|
|
|
|||||
Net (decrease) increase in cash and cash equivalents and restricted cash |
( |
) |
||||||
Cash and cash equivalents and restricted cash, beginning of the period |
||||||||
|
|
|
|
|||||
Cash and cash equivalents and restricted cash, end of the period |
$ |
$ |
||||||
|
|
|
|
|||||
Supplemental disclosure of non-cash investing and financing activities: |
||||||||
Conversion of convertible preferred stock to Class A common stock in connection with the reverse recapitalization |
$ |
$ |
— |
|||||
Recapitalization transaction costs liability incurred |
$ |
$ |
— |
|||||
Conversion of convertible notes and accrued interest to Class A common stock in connection with the reverse recapitalization |
$ |
$ |
— |
|||||
Conversion of B-1 Warrants to Class A common stock in connection with the reverse recapitalization |
$ |
$ |
— |
|||||
Discharge of PIPE promissory note in connection with the reverse recapitalization |
$ |
$ |
— |
|||||
Supplemental disclosure of cash (received) paid for: |
||||||||
Income taxes |
$ |
( |
) |
$ |
( |
) | ||
Interest |
$ |
$ |
||||||
The following table provides a reconciliation of cash and cash equivalents, and restricted cash reported within the condensed consolidated balance sheet with the same as shown in the condensed consolidated statement of cash flows. |
||||||||
Cash and cash equivalents |
$ |
$ |
||||||
Restricted cash |
||||||||
|
|
|
|
|||||
Total cash, cash equivalents, and restricted cash, end of period |
$ |
$ |
||||||
|
|
|
|
As of March 31, 2022 |
||||||||||||
As Reported |
Adjustment |
As Restated |
||||||||||
Condensed Consolidated Balance Sheets |
||||||||||||
Liabilities, and stockholders’ equity |
||||||||||||
Earnout liabilities |
$ |
$ |
||||||||||
Total liabilities |
$ |
$ |
$ |
|||||||||
Stockholders’ equity: |
||||||||||||
Additional paid-in capital |
$ |
$ |
( |
) |
$ |
|||||||
Accumulated deficit |
$ |
( |
) |
$ |
$ |
( |
) | |||||
Total stockholders’ equity |
$ |
$ |
( |
) |
$ |
|||||||
For the Three Months Ended March 31, 2022 |
||||||||||||
As Reported |
Adjustment |
As Restated |
||||||||||
Condensed Consolidated Statements of Operations |
||||||||||||
Other (income) expenses: |
||||||||||||
Changes in fair value of earnout liabilities |
$ |
$ |
( |
) |
$ |
( |
) | |||||
Total other (income) expense, net |
$ |
$ |
( |
) |
$ |
|||||||
Net (loss) income before provision (benefit) for income taxes |
$ |
( |
) |
$ |
$ |
( |
) | |||||
Net (loss) income |
$ |
( |
) |
$ |
$ |
( |
) | |||||
For the Three Months Ended March 31, 2022 |
||||||||||||
As Reported |
Adjustment |
As Restated |
||||||||||
Condensed Consolidated Statement of Stockholders’ Equity |
||||||||||||
Class A Common Stock Shares |
$ |
$ |
( |
) |
$ |
|||||||
Class A Common Stock Amount |
$ |
$ |
$ |
|||||||||
Additional paid-in capital |
$ |
$ |
( |
) |
$ |
|||||||
Accumulated Deficit |
$ |
$ |
( |
) |
$ |
|||||||
Total stockholders’ equity |
$ |
$ |
( |
) |
$ |
|||||||
For the Three Months Ended March 31, 2022 |
||||||||||||
As Reported |
Adjustment |
As Restated |
||||||||||
Condensed Consolidated Statements of Cash Flows |
||||||||||||
Operating activities |
||||||||||||
Net (loss) income |
$ |
( |
) |
$ |
$ |
( |
) | |||||
Changes in fair value of earnout liabilities |
$ |
$ |
( |
) |
$ |
( |
) | |||||
Member advances, service revenue |
$ |
( |
) |
$ |
$ |
( |
) | |||||
Net cash (used in) provided by operating activities |
$ |
( |
) |
$ |
$ |
( |
) | |||||
Investing activities |
||||||||||||
Net disbursements and collections of Member advances |
$ |
$ |
( |
) |
$ |
( |
) | |||||
Net cash (used in) provided by investing activities |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||
For the Three Months Ended March 31, 2021 |
||||||||||||
As Reported |
Adjustment |
As Restated |
||||||||||
Condensed Consolidated Statements of Cash Flows |
||||||||||||
Operating activities |
||||||||||||
Member advances, service revenue |
$ |
$ |
( |
) |
$ |
|||||||
Net cash (used in) provided by operating activities |
$ |
$ |
( |
) |
$ |
( |
) | |||||
Investing activities |
||||||||||||
Net disbursements and collections of Member advances |
$ |
$ |
$ |
|||||||||
Net cash (used in) provided by investing activities |
$ |
$ |
$ |
Assets |
| |||
Cash and cash equivalents |
$ | |||
Member advances, net of allowance for unrecoverable advances of $ |
||||
Debt and credit facility commitment fee, current |
||||
Debt facility commitment fee, long-term |
||||
|
|
|||
Total assets |
$ |
|||
|
|
|||
Liabilities |
| |||
Credit facility |
||||
Debt facility |
$ | |||
|
|
|||
Total liabilities |
$ |
|||
|
|
March 31, 2022 (as Restated) |
Level 1 |
Level 2 |
Level 3 |
Total |
||||||||||||
Assets |
||||||||||||||||
Marketable securities |
$ | $ | — | $ | — | $ | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total assets |
$ |
$ |
— |
$ |
— |
$ |
||||||||||
|
|
|
|
|
|
|
|
|||||||||
Liabilities |
||||||||||||||||
Warrant liabilities—public warrants |
$ | $ | — | $ | — | $ | ||||||||||
Warrant liabilities—private placement warrants |
$ | — | $ | — | $ | $ | ||||||||||
Earnout liabilities |
$ | — | $ | — | $ | $ | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
December 31, 2021 |
Level 1 |
Level 2 |
Level 3 |
Total |
||||||||||||
Assets |
||||||||||||||||
Marketable securities |
$ | $ | — | $ | — | $ | ||||||||||
Derivative asset on loans to stockholders |
— | — | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total assets |
$ |
$ |
— |
$ |
$ |
|||||||||||
|
|
|
|
|
|
|
|
|||||||||
Liabilities |
||||||||||||||||
Warrant liability |
$ | — | $ | — | $ | $ | ||||||||||
Note payable |
— | — | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total liabilities |
$ |
— |
$ |
— |
$ |
$ |
||||||||||
|
|
|
|
|
|
|
|
Opening value at January 1, 2021 |
$ |
|||
Amendment to loan to stockholder |
||||
Change in fair value during the year |
||||
|
|
|||
Ending value at December 31, 2021 |
||||
Change in fair value during the period |
( |
) | ||
Exercise of call option |
( |
) | ||
|
|
|||
Ending value at March 31, 2022 |
$ |
|||
|
|
Expected volatility |
% | |||
Risk-free interest rate |
% | |||
Remaining term |
Opening value at January 1, 2021 |
$ |
|||
Initial fair value at the original issuance date |
||||
Change in fair value during the year |
||||
|
|
|||
Ending value at December 31, 2021 |
||||
Change in fair value during the year |
( |
) | ||
Exercise of warrant |
( |
) | ||
|
|
|||
Ending value at March 31, 2022 |
$ |
|||
|
|
Expected volatility |
% | |||
Risk-free interest rate |
% | |||
Remaining term |
Opening value at January 1, 2021 |
$ |
|||
Fair value at issuance |
||||
Change in fair value during the year |
||||
|
|
|||
Ending value at December 31, 2021 |
||||
Change in fair value during the year |
( |
) | ||
Discharge of obligation through the issuance of Common Stock |
( |
) | ||
|
|
|||
Ending value at March 31, 2022 |
$ |
|||
|
|
Opening value at January 1, 2022 |
$ |
|||
Initial fair value at the merger date |
||||
Change in fair value during the period |
||||
Ending value at March 31, 2022 |
$ |
|||
March 31, 2022 |
||||
Exercise Price |
$ | |||
Expected Volatility |
||||
Risk-free interest rate |
||||
Remaining term |
||||
Dividend yield |
Opening value at January 1, 2022 |
$ |
|||
Initial fair value at the merger date |
||||
Change in fair value during the period |
( |
) | ||
Ending value at March 31 , 2022 |
$ |
|||
March 31, 2022 |
||||
Exercise Price |
$ |
|||
Expected volatility |
||||
Risk-free interest rate |
||||
Remaining term |
||||
Dividend yield |
• | Historical financial performance; |
• | The Company’s business strategy; |
• | Industry information, such as external market conditions and trends; |
• | Lack of marketability of the Common Stock; |
• | Likelihood of achieving a liquidity event, such as an initial public offering, special-purpose acquisition company (“SPAC”) merger, or strategic sale given prevailing market conditions and the nature and history of the Company’s business; |
• |
Prices, privileges, powers, preferences, and rights of the convertible preferred stock relative to those of the Common Stock; |
• |
Forecasted cash flow projections for the Company; |
• |
Publicly traded price of the SPAC; |
• |
Primary preferred stock financings and secondary common stock transactions of the Company’s equity securities; |
• |
Lack of marketability/illiquidity of the common stock underlying the Company’s stock-based awards involving securities in a private company; and |
• |
Macroeconomic conditions. |
For the Three Months Ended March 31, |
||||||||
2022 |
2021 |
|||||||
Numerator |
||||||||
Net (loss) income |
$ | ( |
) | $ | ||||
Less: noncumulative dividend to convertible preferred stockholders |
( |
) | ||||||
Less: undistributed earnings to participating securities |
— | |||||||
|
|
|
|
|||||
Net (loss) income attributed to common stockholders—basic |
( |
) | ||||||
Add: undistributed earnings reallocated to common stockholders |
— | |||||||
|
|
|
|
|||||
Net (loss) income attributed to common stockholders—diluted |
$ | ( |
) | $ | ||||
Denominator |
||||||||
Weighted-average shares of common stock—basic |
||||||||
Dilutive effect of convertible preferred stock |
||||||||
Dilutive effect of equity incentive awards |
||||||||
|
|
|
|
|||||
Weighted-average shares of common stock—diluted |
||||||||
Net (loss) income per share |
||||||||
Basic |
$ | ( |
) | $ | ||||
Diluted |
$ | ( |
) | $ |
For the Three Months Ended March 31, |
||||||||
2022 |
2021 |
|||||||
Equity incentive awards |
||||||||
Convertible deb t |
|
|
|
|
|
|
|
|
Convertible preferred stock |
||||||||
Series B-1 warrants |
||||||||
|
|
|
|
|||||
Total |
||||||||
|
|
|
|
Cash |
$ | |
||
Other assets |
||||
Accrued expenses |
( |
) | ||
Warrant liability - public |
( |
) | ||
Warrant liability - private |
( |
) | ||
Earnout liabilities (Restated) |
( |
) | ||
|
|
|||
Net assets acquired |
$ |
|||
|
|
(i) | in the event of a change of control pursuant to which Dave Stockholders receive, or have the right to receive, cash, securities or other property attributing a value of at least twelve dollars and fifty cents ($12.50) to each share of Class A Common Stock (as agreed in good faith by the Sponsor and the Board), then Triggering Event I shall be deemed to have occurred and; |
(ii) | in the event that, and as often as, the number of outstanding shares of Class A Common Stock is changed by reason of any dividend, subdivision, reclassification, recapitalization, split, combination, exchange or any similar event, then the applicable Common Share Price (as defined in the Business Agreement) threshold (i.e., twelve dollars and fifty cents ($C ombinationpurposes of the Business Combination Agreement (and the Founder Holder Agreement), in each case be equitably adjusted to reflect such change; and |
(iii) | in the event of a change of control pursuant to which Dave Stockholders receive, or have the right to receive, cash, securities or other property attributing a value of at least fifteen dollars ($15.00) to each share of Class A Common Stock (as agreed in good faith by Sponsor and the Board), then Triggering Event II shall be deemed to have occurred and; |
(iv) | in the event that, and as often as, the number of outstanding shares of Class A Common Stock is changed by reason of any dividend, subdivision, reclassification, recapitalization, split, combination, exchange or any similar event, then the applicable Common Share Price threshold (i.e., fifteen dollars ($ Business Combination Agreement (and the Founder Holder Agreement), in each case be equitably adjusted to reflect such change. |
Class A |
Class V |
|||||||
Common stock outstanding on December 31, 2021 |
|
|
|
| ||||
Common stock activity between December 31, 2021 and January 5, 2022 |
|
|
|
| ||||
Exercise of derivative asset and paydown of stockholder loans |
( |
) | |
|
— |
| ||
Issuance of Class A common stock for stock option exercises |
|
|
|
|
|
|
— |
|
Repurchase of Class A common stock |
|
|
( |
) |
|
|
— |
|
|
|
|
|
|
|
|
|
|
Common stock outstanding prior to the Business Combination |
|
|
|
| ||||
Conversion of preferred stock to Class A common stock |
|
|
— |
| ||||
Common stock attributable to VPCC |
|
|
— |
| ||||
|
|
|
|
|
|
|
|
|
Adjustment related to Reverse Recapitalization * |
|
|
— |
| ||||
Founder Holder shares (Restated) |
|
|
— |
| ||||
Conversion of 2019 convertible notes and accrued interest to Class A common |
|
|
— |
| ||||
Exercise of Series B-1 preferred stock warrants, net of settlement |
|
|
— |
| ||||
Issuance of Class A common stock pursuant to the PIPE financing |
|
|
— |
| ||||
|
|
|
|
|
|
|
|
|
Total shares of common stock as of closing of Business Combination and related transactions |
|
|
|
| ||||
|
|
|
|
|
|
|
|
|
March 31, 2022 |
December 31, 2021 |
|||||||
Marketable securities |
$ | $ | ||||||
|
|
|
|
|||||
Total |
$ |
$ |
||||||
|
|
|
|
Days From Origination |
Gross Member Advances |
Allowance for Unrecoverable Advances |
Member Advances, Net |
|||||||||
1-10 |
$ | $ | ( |
) | $ | |||||||
11-30 |
( |
) | ||||||||||
31-60 |
( |
) | ||||||||||
61-90 |
( |
) | ||||||||||
91-120 |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Total |
$ |
$ |
( |
) |
$ |
Days From Origination |
Gross Member Advances |
Allowance for Unrecoverable Advances |
Member Advances, Net |
|||||||||
1-10 |
$ | $ | ( |
) | $ | |||||||
11-30 |
( |
) | ||||||||||
31-60 |
( |
) | ||||||||||
61-90 |
( |
) | ||||||||||
91-120 |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Total |
$ |
$ |
( |
) |
$ |
Opening allowance balance at January 1, 2022 |
$ |
|||
Plus: provision for unrecoverable advances |
||||
Less: amounts written-off |
( |
) | ||
|
|
|||
Ending allowance balance at March 31, 2022 |
$ |
|||
|
|
Opening allowance balance at January 1. 2021 |
$ |
|||
Plus: provision for unrecoverable advances |
||||
Less: amounts written-off |
( |
) | ||
|
|
|||
Ending allowance balance at March 31, 2021 |
$ |
|||
|
|
March 31, 2022 |
December 31, 2021 |
|||||||
Computer equipment |
$ | $ | ||||||
Leasehold improvements |
||||||||
Furniture and fixtures |
||||||||
|
|
|
|
|||||
Total property and equipment |
||||||||
Less: accumulated depreciation |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Property and equipment, net |
$ |
$ |
||||||
|
|
|
|
March 31, 2022 |
December 31, 2021 |
|||||||||||||||||||||||||||
Weighted Average Useful Lives |
Gross Carrying Value |
Accumulated Amortization |
Net Book Value |
Gross Carrying Value |
Accumulated Amortization |
Net Book Value |
||||||||||||||||||||||
Internally developed software |
$ | $ | ( |
) | $ | $ | $ | ( |
) | $ | ||||||||||||||||||
Domain name |
( |
) | ( |
) | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Intangible assets, net |
$ |
$ |
( |
) |
$ |
$ |
$ |
( |
) |
$ |
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
2022 (remaining) |
$ | |||
2023 |
||||
2024 |
||||
2025 |
||||
2026 |
||||
Thereafter |
||||
|
|
|||
Total future amortization |
$ |
|||
|
|
March 31, 2022 |
December 31, 2021 |
|||||||
Accrued charitable contributions |
$ | |||||||
Accrued compensation |
||||||||
Sales tax payable |
||||||||
Accrued professional and program fees |
||||||||
Other |
||||||||
|
|
|
|
|||||
Total |
$ |
$ |
||||||
|
|
|
|
• | in whole and not in part; |
• | at a price of $ |
• | upon a minimum of |
• | in whole and not in part; |
• | at $ |
• | if, and only if, the closing price of Class A Common Stock equals or exceeds $ |
For the Three Months Ended |
||||||||
March 31, 2022 |
March 31, 2021 |
|||||||
(unaudited) |
(unaudited) |
|||||||
Operating lease cost |
$ | $ | ||||||
Short-term lease cost |
||||||||
Variable lease cost |
||||||||
|
|
|
|
|||||
Total lease cost |
$ |
$ |
||||||
|
|
|
|
(unaudited) For the Three Months Ended March 31, 2022 |
||||
Other information: |
||||
Cash paid for operating leases |
$ | |||
Right-of-use |
$ | |||
Weighted-average remaining lease term - operating lease |
||||
Weighted-average discount rate - operating lease |
% |
Year |
(unaudited) Third-Party Commitment |
(unaudited) Related-Party Commitment |
(unaudited) Total |
|||||||||
2022 (remaining) |
$ | $ | $ | |||||||||
2023 |
||||||||||||
2024 |
||||||||||||
2025 |
||||||||||||
Thereafter |
||||||||||||
|
|
|
|
|
|
|||||||
Total minimum lease payments |
$ |
$ |
$ |
|||||||||
|
|
|
|
|
|
|||||||
Less: imputed interest |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Total lease liabilities |
$ |
$ |
$ |
|||||||||
|
|
|
|
|
|
2022: Expected term |
||||
Risk-free interest rate |
% | |||
Expected dividend yield |
% | |||
Expected volatility |
% |
Shares |
Weighted- Average Exercise Price |
|||||||
Options outstanding, January 1, 2022 |
$ | |||||||
Granted |
$ | |||||||
Exercised |
( |
) | $ | |||||
Forfeited |
( |
) | $ | |||||
Expired |
( |
) | $ | |||||
|
|
|||||||
Options outstanding, March 31, 2022 |
$ | |||||||
|
|
|||||||
Nonvested options, March 31, 2022 |
$ | |||||||
|
|
|||||||
Vested and exercisable, March 31, 2022 |
$ | |||||||
|
|
Remaining term |
||||
Risk-free interest rate |
% | |||
Expected dividend yield |
% | |||
Expected volatility |
% |
Year |
Related-Party Commitment |
|||
2022 (remaining) |
$ | |||
2023 |
||||
2024 |
||||
2025 |
||||
Thereafter |
||||
|
|
|||
Total minimum lease payments |
$ |
|||
|
|
|||
Less: imputed interest |
( |
) | ||
|
|
|||
Total lease liabilities |
$ |
|||
|
|
For the Three Months Ended March 31, |
Change |
|||||||||||||||
(in thousands, except for percentages) |
$ |
% |
||||||||||||||
2022 |
2021 |
2022/2021 |
2022/2021 |
|||||||||||||
Service based revenue, net |
||||||||||||||||
Processing fees, net |
$ | 20,978 | $ | 17,400 | $ | 3,578 | 21 | % | ||||||||
Tips |
13,948 | 9,999 | 3,949 | 39 | % | |||||||||||
Subscriptions |
4,154 | 4,872 | (718 | ) | -15 | % | ||||||||||
Other |
188 | 147 | 41 | 28 | % | |||||||||||
Transaction based revenue, net |
3,283 | 2,008 | 1,275 | 63 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Total |
$ |
42,551 |
$ |
34,426 |
$ |
8,125 |
24 | % | ||||||||
|
|
|
|
|
|
For the Three Months Ended March 31, |
Change |
|||||||||||||||
(in thousands, except for percentages) |
$ |
% |
||||||||||||||
2022 |
2021 |
2022/2021 |
2022/2021 |
|||||||||||||
Provision for unrecoverable advances |
$ | 13,785 | $ | 3,538 | $ | 10,247 | 290 | % | ||||||||
Processing and servicing fees |
6,543 | 5,220 | 1,323 | 25 | % | |||||||||||
Advertising and marketing |
12,204 | 14,040 | (1,836 | ) | -13 | % | ||||||||||
Compensation and benefits |
17,894 | 9,384 | 8,510 | 91 | % | |||||||||||
Other operating expenses |
14,798 | 12,577 | 2,221 | 18 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Total |
$ |
65,224 |
$ |
44,759 |
$ |
20,465 |
46 | % | ||||||||
|
|
|
|
|
|
• | an increase in payroll and related costs of approximately $5.6 million, primarily due to hiring and increased headcount throughout the business; |
• | an increase in consultants and contractor costs of approximately $1.4 million, primarily due to our need to supplement recruiting efforts, increase IT security, marketing, and augmenting customer service resources; and |
• | an increase in stock-based compensation of approximately $1.5 million, primarily due to the cumulative expense related to stock options granted to a certain executive during 2021which achieved certain performance conditions associated with the close of the Business Combination. |
• | an increase in insurance related costs of $1.8 million, primarily related to Director and Officer Insurance premiums; |
• | an increase in accounting costs of approximately $0.5 million, primarily related to various audit, tax and Sarbanes Oxley compliance readiness related fees associated with the Business Combination in January 2022; |
• | an increase in technology and infrastructure expenses of approximately $1.1 million, primarily due to increased spending to support the growth of our business and development of new products and features; |
• | an increase in expenses related to our Checking Product of approximately $1.0 million, primarily attributable to the growth in Members and the number of transactions processed; |
• | an increase in legal fees of approximately $0.6 million, primarily due to ongoing litigation, compliance, employment and general corporate related matters; |
• | an increase in various administrative fees of approximately $0.5 million primarily due to increases license and fees, travel and entertainment, and company meetings; |
• | an increase in depreciation and amortization of $0.5 million, primarily due to equipment purchases for increased headcount and amortization of internally developed software; |
• | an increase in rent expense of $0.4 million, due to additional leased office space; offset by |
• | a decrease in chargeback related expenses of approximately $4.0 million, primarily due to non-recurring fraudulent activity in relation to our Checking Product (see “Risk Factors—Risks related to our Business and Industry—Fraudulent and other illegal activity involving our products and services could lead to reputational damage to us, reduce the use of our platform and services and may adversely affect our financial position and results of operations.”); and |
• | a decrease in charitable contribution expenses of approximately $0.2 million, primarily due to decreased amounts pledged to charitable meal donations related to increased Members’ tips. |
For the Three Months Ended March 31, |
Change |
|||||||||||||||
(in thousands, except for percentages) |
$ |
% |
||||||||||||||
2022 |
2021 |
2022/2021 |
2022/2021 |
|||||||||||||
Interest income |
$ | (13 | ) | $ | (70 | ) | $ | 57 | -81 | % | ||||||
Interest expense |
1,555 | 277 | 1,278 | 461 | % | |||||||||||
Legal settlement and litigation expenses |
— | 368 | (368 | ) | -100 | % | ||||||||||
Other strategic financing and transactional expenses |
961 | 108 | 853 | 790 | % | |||||||||||
Changes in fair value of earnout liabilities |
(2,040 | ) | — | (2,040 | ) | -100 | % | |||||||||
Changes in fair value of derivative asset on loans to stockholders |
5,572 | (17,146 | ) | 22,718 | -132 | % | ||||||||||
Changes in fair value of warrant liability |
4,065 | 2,186 | 1,879 | 86 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Total |
$ |
10,100 |
$ |
(14,277 |
) |
$ |
24,377 |
-171 | % | |||||||
|
|
|
|
|
|
For the Three Months Ended March 31, |
Change |
|||||||||||||||
(in thousands, except for percentages) |
$ |
% |
||||||||||||||
2022 |
2021 |
2022/2021 |
2022/2021 |
|||||||||||||
Provision (benefit) for income taxes |
$ | 22 | $ | (8 | ) | $ | 30 | -375 | % | |||||||
|
|
|
|
|
|
|||||||||||
Total |
$ |
22 |
$ |
(8 |
) |
$ |
30 |
-375 |
% | |||||||
|
|
|
|
|
|
(in thousands) |
For the Three Months Ended March 31, |
|||||||
2022 |
2021 |
|||||||
Net (loss) income |
$ | (32,795 | ) | $ | 3,952 | |||
Interest expense |
1,542 | 207 | ||||||
Provision (benefit) for income taxes |
22 | (8 | ) | |||||
Depreciation and amortization |
1,105 | 598 | ||||||
Stock-based compensation |
3,190 | 1,694 | ||||||
Legal settlement and litigation expenses |
— | 368 | ||||||
Other strategic financing and transactional expenses |
961 | 108 | ||||||
Changes in fair value of earnout liabilities |
(2,040 | ) | — | |||||
Changes in fair value of derivative asset on loans to stockholders |
5,572 | (17,146 | ) | |||||
Changes in fair value of warrant liability |
4,065 | 2,186 | ||||||
|
|
|
|
|||||
Total |
$ |
(18,378 |
) |
$ |
(8,041 |
) | ||
|
|
|
|
Total cash (used in) provided by: |
For the Three Months Ended March 31, |
|||||||
(in thousands) |
2022 |
2021 |
||||||
Operating activities |
$ | (12,512 | ) | $ | (1,680 | ) | ||
Investing activities |
(297,568 | ) | 4,909 | |||||
Financing activities |
301,724 | 15,569 | ||||||
|
|
|
|
|||||
Net (decrease) increase in cash and cash equivalents and restricted cash |
$ |
(8,356 |
) |
$ |
18,798 |
|||
|
|
|
|
• | Level 1. Quoted prices in active markets for identical assets or liabilities. |
• | Level 2. Observable inputs other than Level 1 quoted prices, such as quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active for identical or similar assets and liabilities, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. |
• | Level 3. Valuations are based on inputs that are unobservable and significant to the overall fair value measurement of the assets or liabilities. Inputs reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model. |
• | Historical financial performance; |
• | Our business strategy; |
• | Industry information, such as external market conditions and trends; |
• | Likelihood of achieving a liquidity event, such as an initial public offering, SPAC merger, or strategic sale given prevailing market conditions and the nature and history of our business; |
• | Prices, privileges, powers, preferences and rights of our convertible preferred stock relative to those of Dave Common Stock; |
• | Forecasted cash flow projections for Dave’s business; |
• | Publicly traded price of the special purpose acquisition company (“SPAC”); |
• | Primary preferred stock financings and secondary common stock transactions of our equity securities; |
• | Lack of marketability/illiquidity of the common stock underlying our stock-based awards involving securities in a private company; and |
• | Macroeconomic conditions. |
• | Dave did not design and maintain certain formal accounting policies, procedures, and internal controls to achieve complete, accurate and timely financial accounting, reporting and disclosures, including internal controls over the period-end financial reporting process addressing financial statement and footnote presentation and disclosures, account reconciliations, and journal entries. Additionally, the lack of a sufficient number of accounting and finance professionals resulted in an inability to consistently establish appropriate authorities and responsibilities in pursuit of Dave’s financial reporting objectives, as demonstrated by, amongst other things, insufficient segregation of duties within the finance and accounting functions. |
• | Dave did not design and maintain effective controls over information technology (“IT”) general controls for information systems that are relevant to the preparation of its financial statements, specifically, with respect to: (i) program change management controls to ensure that IT program and data changes affecting financial IT applications and underlying accounting records are identified, tested, authorized and implemented appropriately; (ii) user access controls to ensure appropriate segregation of duties and that adequately restrict user and privileged access to financial applications, programs, and data to appropriate company personnel: and (iii) computer operations controls to ensure that critical batch jobs are monitored and data backups are authorized and monitored. |
Dave Inc. | ||||
Dated: August 22, 2022 | /s/ Jason Wilk | |||
Jason Wilk | ||||
Chief Executive Officer and Director | ||||
Dated: August 22, 2022 | /s/ Kyle Beilman | |||
Kyle Beilman | ||||
Chief Financial Officer |
Exhibit 31.1
CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a)
UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Jason Wilk, certify
1. | I have reviewed this Amendment No. 1 to the Quarterly Report on Form 10-Q for the quarter ended March 31, 2022 of Dave Inc.; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrants other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have: |
a. | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b. | Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313; |
c. | Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d. | Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and |
5. | The registrants other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions): |
a. | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and |
b. | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal controls over financial reporting. |
Date: August 22, 2022 | By: | /s/ Jason Wilk | ||||
Jason Wilk | ||||||
Chief Executive Officer and Director | ||||||
(Principal Executive Officer) |
Exhibit 31.2
CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a)
UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Kyle Beilman, certify
1. | I have reviewed this Amendment No. 1 to the Quarterly Report on Form 10-Q for the quarter ended March 31, 2022 of Dave Inc.; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrants other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have: |
a. | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b. | Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313; |
c. | Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d. | Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and |
5. | The registrants other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions): |
a. | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and |
b. | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal controls over financial reporting. |
Date: August 22, 2022 | By: | /s/ Kyle Beilman | ||||
Kyle Beilman | ||||||
Chief Financial Officer | ||||||
(Principal Financial Officer) |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with Amendment No. 1 to the Quarterly Report of Dave Inc. (the Company) on Form 10-Q for the period ended March 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the Report), Jason Wilk, Chief Executive Officer of the Company, and Kyle Beilman, Chief Financial Officer of the Company, do each hereby certify pursuant to 18 of U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:
(1) | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: August 22, 2022 | /s/ Jason Wilk | |||
Jason Wilk | ||||
Chief Executive Officer and Director | ||||
(Principal Executive Officer) | ||||
/s/ Kyle Beilman | ||||
Kyle Beilman | ||||
Chief Financial Officer | ||||
(Principal Financial Officer) |